Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
Liebenberg, Lenine J. P.
MetadataShow full item record
CitationLiebenberg, Lenine J. P., Derseree Archary, Aida Sivro, and Douglas S. Kwon. 2017. “Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention.” Genome Medicine 9 (1): 74. doi:10.1186/s13073-017-0469-2. http://dx.doi.org/10.1186/s13073-017-0469-2.
AbstractEditorial summary Advances in molecular tools to characterize the microbiome have led to the discovery of unique roles for microbes in human disease. Findings that the female genital microbiome can influence HIV acquisition and prevention emphasize the importance of microbiome analysis in clinical trials that assess the efficacy of HIV prevention interventions.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:34375026
- HMS Scholarly Articles